It has been reported that EPC transplantation mitigated the increases in the levels of hippocampal Tau phosphorylation and its upstream GSK-3β in an experimental model of Alzheimer’s disease [43]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.